A retrospective study of comparing 6- and 12-months adherence and persistence among dulaglutide (DU) vs. matched semaglutide
Latest Information Update: 09 Aug 2021
At a glance
- Drugs Dulaglutide (Primary) ; Semaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 09 Aug 2021 New trial record
- 29 Jun 2021 Results presented at the 81st Annual Scientific Sessions of the American Diabetes Association